GlassScriptPhysician profile
Federico G Depuy
NPI 1831535186
$68,058.99
in general payments reported to CMS, 2019-2025
38 companies · $4,299 in 2025
The $4,299 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $1,866 · 2021: $2,760 · 2022: $9,027 · 2023: $26K · 2024: $23K · 2025: $4,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $21K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $19K · Food and Beverage: $12K · Consulting Fee: $1,590 · Grant: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $21,198.40 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $18,700.00 |
| Food and Beverage | $12,427.65 |
| Consulting Fee | $1,590.00 |
| Grant | $195.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $24,295.40 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $16,612.76 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Symplicity G3 |
| Edwards Lifesciences Corporation | $7,761.94 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Penumbra, INC. | $5,197.05 | 2022-2025 | Indigo System, Penumbra Coil 400 |
| Abiomed | $3,458.88 | 2022-2025 | Impella |
| Boston Scientific Corporation | $2,524.92 | 2019-2025 | Watchman, Avvigo Guidance System, Opticross |
| Terumo Medical Corporation | $956.66 | 2021-2024 | Glidewire, Glidesheath Slender, Metacross Otw |
| Abbott Laboratories | $937.43 | 2019-2025 | Mitraclip, Optis, Perclose Prostyle |
| Ancora Heart, INC. | $751.16 | 2024 | Accucinch |
| Inari Medical, INC. | $735.88 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Incorporated | $730.62 | 2023 | Cook Celect |
| Medtronic Vascular, INC. | $659.16 | 2020 | |
| Asahi Intecc USA, INC. | $575.29 | 2021-2025 | Asahi Coronary Wires |
| Janssen Pharmaceuticals, INC | $486.76 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $351.38 | 2019-2024 | Farxiga |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $298.90 | 2020-2023 | Diamondback Coronary |
| Chiesi USA, INC. | $185.67 | 2021-2022 | |
| Angiodynamics, INC. | $183.46 | 2023 | Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $173.89 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $161.51 | 2022-2024 | Lifevest |
| Esperion Therapeutics, INC. | $124.52 | 2022-2023 | Nexletol |
| Philips North America LLC | $115.82 | 2019 | |
| Kestra Medical Technology Services, INC. | $114.42 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $107.74 | 2022-2024 | Camzyos |
| Acist Medical Systems, INC. | $79.63 | 2025 | |
| Amgen INC. | $73.85 | 2023-2025 | Repatha, Repatha |
| Pfizer INC. | $61.61 | 2022-2025 | |
| Amarin Pharma, INC. | $57.47 | 2021 | |
| Cardiva Medical, INC. | $56.76 | 2024-2025 | Ensoetm, Savvywire |
| Kiniksa Pharmaceuticals International, Plc | $37.69 | 2024 | Arcalyst |
| Aroa Biosurgery Incorporated | $34.37 | 2024 | |
| Alnylam Pharmaceuticals INC. | $32.82 | 2025 | Onpattro |
| Solventum Corporation | $26.05 | 2024 | Prevena, V.A.C. Veraflo |
| Livanova USA, INC. | $24.44 | 2023 | Lifesparc |
| Heartflow, INC. | $21.07 | 2025 | |
| Novo Nordisk INC | $20.56 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.08 | 2022 | |
| Merck Sharp & Dohme LLC | $14.37 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Federico Depuy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.